Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients (Q41463849)

From Wikidata
Jump to navigation Jump to search
scientific article published on January 1996
edit
Language Label Description Also known as
English
Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients
scientific article published on January 1996

    Statements

    Letrozole (CGS 20267), a new oral aromatase inhibitor for the treatment of advanced breast cancer in postmenopausal patients (English)
    1 January 1996
    35 Suppl 5

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit